HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A–cyclophilin A interaction to cyclophilin inhibitors
Udayan Chatterji(Scripps Research Institute), Philippe Gallay(Scripps Research Institute), Paul Targett‐Adams(Medivir (Sweden)), Craig E. Cameron(University of North Carolina at Chapel Hill), Michael Bobardt(Scripps Research Institute), Tanya Parkinson(Pfizer (United Kingdom)), Daniel G. Cordek(Pennsylvania State University), Stefan Wieland(Scripps Research Institute), Francis V. Chisari(Scripps Research Institute), Grégoire Vuagniaux(Debiopharm (Switzerland)), Precious Lim(Scripps Research Institute)
Cited by 120
Related Papers
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
|Science|1996|4.9k
Genomic analysis of the host response to hepatitis C virus infection
|Proceedings of the National Academy of Sciences|2002|1.2k
CD8 <sup>+</sup> T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection
|Journal of Virology|2002|974
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851